1987
DOI: 10.1016/0223-5234(87)90268-6
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and neuroleptic activity of some trans-(2-aminomethyl)-cyclopentyl aryl ketones

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

1994
1994
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Chiral cyclopentanes bearing two contiguous stereogenic centers are widely found in natural products and biologically active molecules and are also important building blocks, in which chiral 2-substituted cyclopentyl aryl ketones are important members (Figure a). For example, compound A has potential neuroleptic activity, and compound B is a selective diacyl glycerolacyltransferase-1 inhibitor. , Erteberel is an ERβ agonist developed by Eli Lily and Company, and its synthesis is derived from 2-arylcyclopentyl aryl ketone . However, examples for the efficient synthesis of chiral 2-substituted cyclopentyl aryl ketone are relatively rare, and most of the reported methods suffer from low stereoselectivities and yields or require chiral starting materials and multiple steps.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Chiral cyclopentanes bearing two contiguous stereogenic centers are widely found in natural products and biologically active molecules and are also important building blocks, in which chiral 2-substituted cyclopentyl aryl ketones are important members (Figure a). For example, compound A has potential neuroleptic activity, and compound B is a selective diacyl glycerolacyltransferase-1 inhibitor. , Erteberel is an ERβ agonist developed by Eli Lily and Company, and its synthesis is derived from 2-arylcyclopentyl aryl ketone . However, examples for the efficient synthesis of chiral 2-substituted cyclopentyl aryl ketone are relatively rare, and most of the reported methods suffer from low stereoselectivities and yields or require chiral starting materials and multiple steps.…”
mentioning
confidence: 99%
“…5−7 For example, compound A has potential neuroleptic activity, and compound B is a selective diacyl glycerolacyltransferase-1 inhibitor. 5,6 Erteberel is an ERβ agonist developed by Eli Lily and Company, and its synthesis is derived from 2-arylcyclopentyl aryl ketone. 7 However, examples for the efficient synthesis of chiral 2-substituted cyclopentyl aryl ketone are relatively rare, 7−10 and most of the reported methods suffer from low stereoselectivities and yields or require chiral starting materials and multiple steps.…”
mentioning
confidence: 99%